Chemical inhibitors of TNFα-IP1 encompass a variety of compounds that target distinct signaling pathways implicated in the regulation of this protein. Cyclosporin A, for instance, inhibits calcineurin, which in turn prevents the activation of NF-AT, a transcription factor that normally enhances the expression of genes related to inflammation, including those involving TNFα-IP1. Dexamethasone operates through inhibition of the NF-κB pathway, thereby reducing the activity of TNFα-IP1 by curtailing the transcription of genes that partake in the inflammatory response. Aspirin achieves its inhibitory effect on TNFα-IP1 by obstructing cyclooxygenase enzymes, leading to a reduction in prostaglandin synthesis, which is crucial for inflammatory signaling processes that TNFα-IP1 engages in. Parthenolide also targets the NF-κB pathway, but it does so by preventing IκB kinase activity, which results in a decrease in TNFα-IP1's role within the pro-inflammatory signaling cascade.
Adding to the repertoire, SP600125 suppresses JNK activity, which is pivotal in the signaling pathways that regulate TNFα-IP1 function, especially in response to stress and cytokines. Bay 11-7082 executes its function by irreversibly inhibiting IκBα phosphorylation, consequently inhibiting NF-κB activity and reducing TNFα-IP1's contribution to this pathway. Similarly, SB203580's selective inhibition of p38 MAPK dampens the MAPK pathway's regulation of TNFα-IP1 activity. PD98059 and U0126, inhibitors of MEK, lead to a downstream reduction in ERK activation in the MAPK pathway, which is influential in regulating TNFα-IP1 activity related to cellular stress signals. PI3K inhibitors LY294002 and Wortmannin result in decreased AKT phosphorylation, thus inhibiting the PI3K/AKT pathway where TNFα-IP1 is involved in mediating signals for cell survival and inflammation. Lastly, Rapamycin's inhibition of mTOR, a central regulator of cell growth, can lead to a concomitant decrease in TNFα-IP1 function as it plays a part in these cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A inhibits calcineurin, which indirectly inhibits TNFα-IP1 by preventing the activation of NF-AT, a transcription factor that increases the expression of genes related to inflammation and TNFα-IP1 is implicated in this pathway. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone inhibits the NF-κB pathway, which reduces the activity of TNFα-IP1 by decreasing the transcription of genes that are involved in inflammatory responses where TNFα-IP1 has a role. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $41.00 | 4 | |
Aspirin inhibits cyclooxygenase enzymes, leading to reduced prostaglandin synthesis. This reduction in prostaglandins can decrease the inflammatory signaling pathways in which TNFα-IP1 is involved. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
Parthenolide inhibits the NF-κB pathway by preventing IκB kinase activity, which results in the functional inhibition of TNFα-IP1 by limiting its role in the pro-inflammatory signaling cascade. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK activity, which is involved in the signaling pathways that regulate TNFα-IP1 function, particularly in response to stress and cytokines. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Bay 11-7082 irreversibly inhibits IκBα phosphorylation, thereby inhibiting NF-κB activity and diminishing the functional contribution of TNFα-IP1 in the NF-κB signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 selectively inhibits p38 MAPK, which is part of the MAPK pathway that regulates TNFα-IP1 activity, particularly in cells responding to stress and cytokines. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 selectively inhibits MEK, which is upstream of the MAPK/ERK pathway, leading to decreased activation of ERK and subsequent reduction in TNFα-IP1 activity within this signaling cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, which reduces AKT phosphorylation and activity, thereby inhibiting the PI3K/AKT pathway where TNFα-IP1 is involved in mediating cell survival signals. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which is a key regulator of cell growth and proliferation. TNFα-IP1 is implicated in these processes, so inhibition of mTOR can lead to decreased TNFα-IP1 function. | ||||||